245 related articles for article (PubMed ID: 8371029)
21. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
22. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
23. Cytokines in mycobacterial infections: in vitro and ex vivo studies.
Flad HD; Gercken J; Hübner L; Schlüter C; Pryjma J; Ernst M
Arch Immunol Ther Exp (Warsz); 1995; 43(2):153-8. PubMed ID: 8744732
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.
Sieling PA; Abrams JS; Yamamura M; Salgame P; Bloom BR; Rea TH; Modlin RL
J Immunol; 1993 Jun; 150(12):5501-10. PubMed ID: 8515073
[TBL] [Abstract][Full Text] [Related]
25. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
Kifayet A; Hussain R
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
[TBL] [Abstract][Full Text] [Related]
26. T cell-monocyte contact enhances tumor necrosis factor-alpha production in response to Mycobacterium leprae.
Sampaio EP; Oliveira RB; Warwick-Davies J; Neto RB; Griffin GE; Shattock RJ
J Infect Dis; 2000 Nov; 182(5):1463-72. PubMed ID: 11023469
[TBL] [Abstract][Full Text] [Related]
27. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
Vieira LM; Sampaio EP; Nery JA; Duppre NC; Albuquerque EC; Scheinberg MA; Sarno EN
Rev Inst Med Trop Sao Paulo; 1996; 38(2):103-11. PubMed ID: 9071029
[TBL] [Abstract][Full Text] [Related]
28. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
29. Suppressive effect of circulating immune complexes from leprosy patients on the lymphocyte proliferation induced by M. leprae antigens in healthy responders.
Tyagi P; Patil SA; Girdhar BK; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):562-9. PubMed ID: 1299711
[TBL] [Abstract][Full Text] [Related]
30. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients.
Bach MA; Wallach D; Flageul B; Cottenot F
Clin Exp Immunol; 1983 Apr; 52(1):107-14. PubMed ID: 6345031
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum CCL2 concomitant with a reduced mycobacterium-induced response leads to disease dissemination in leprosy.
Hasan Z; Jamil B; Zaidi I; Zafar S; Khan AA; Hussain R
Scand J Immunol; 2006 Mar; 63(3):241-7. PubMed ID: 16499578
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma responses to candidate leprosy skin-test reagents detect exposure to leprosy in an endemic population.
Manandhar R; LeMaster JW; Butlin CR; Brennan PJ; Roche PW
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):40-8. PubMed ID: 10834068
[TBL] [Abstract][Full Text] [Related]
33. Clinical, immunological and histological aspects of an uncommon type II reaction in patients with lepromatous leprosy.
Esquenazi D; Moreira AL; Miranda A; Nery JA; Alvarenga FF; Sarno EN; Pereira GM
Clin Exp Dermatol; 2008 May; 33(3):294-7. PubMed ID: 18261142
[TBL] [Abstract][Full Text] [Related]
34. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
[TBL] [Abstract][Full Text] [Related]
35. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
[TBL] [Abstract][Full Text] [Related]
36. Th2-type immune response observed in healthy individuals to sonicate antigen prepared from the most prevalent Mycobacterium tuberculosis strain with single copy of IS6110.
Rajavelu P; Das SD
FEMS Immunol Med Microbiol; 2005 Jul; 45(1):95-102. PubMed ID: 15985228
[TBL] [Abstract][Full Text] [Related]
37. Evidence that the Mitsuda reaction to Mycobacterium leprae can be mediated by lymphocytes responsive to Mycobacterium tuberculosis.
Roberts PP; Dockrell HM; McAdam KP
Clin Exp Immunol; 1988 Jun; 72(3):390-3. PubMed ID: 2458870
[TBL] [Abstract][Full Text] [Related]
38. In vitro stimulation of lymphocytes with an antigen fraction prepared from Mycobacterium leprae and tuberculin PPD in contacts and non-contacts of leprosy patients.
Reitan LJ; Closs O
Clin Exp Immunol; 1984 Aug; 57(2):315-23. PubMed ID: 6380833
[TBL] [Abstract][Full Text] [Related]
39. Involvement of TNF-Producing CD8
Silva PHL; Santos LN; Mendes MA; Nery JAC; Sarno EN; Esquenazi D
Am J Trop Med Hyg; 2019 Feb; 100(2):377-385. PubMed ID: 30652669
[TBL] [Abstract][Full Text] [Related]
40. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
